Zhijie Xu

ORCID: 0000-0003-2047-883X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ferroptosis and cancer prognosis
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Epigenetics and DNA Methylation
  • MicroRNA in disease regulation
  • Circular RNAs in diseases
  • Cancer Immunotherapy and Biomarkers
  • Cancer, Hypoxia, and Metabolism
  • Extracellular vesicles in disease
  • Autophagy in Disease and Therapy
  • Nanoplatforms for cancer theranostics
  • Immune cells in cancer
  • RNA Interference and Gene Delivery
  • Renal cell carcinoma treatment
  • Cancer Mechanisms and Therapy
  • Cancer-related gene regulation
  • RNA Research and Splicing
  • Ubiquitin and proteasome pathways
  • Cancer, Lipids, and Metabolism
  • Viral-associated cancers and disorders
  • Cancer Genomics and Diagnostics
  • Inflammasome and immune disorders
  • Glioma Diagnosis and Treatment
  • Immunotherapy and Immune Responses
  • Lung Cancer Research Studies

Xiangya Hospital Central South University
2016-2025

Central South University
2016-2025

Zhejiang University
2018-2025

University of South China
2025

China Medical University
2021-2025

Shandong Academy of Sciences
2023-2025

Qilu University of Technology
2023-2025

Shandong University
2025

First Affiliated Hospital Zhejiang University
2020-2024

University of Huddersfield
2019-2024

Ferroptosis is an iron-dependent cell death process that plays important regulatory roles in the occurrence and development of cancers, including hepatocellular carcinoma (HCC). Moreover, molecular events surrounding aberrantly expressed long non-coding RNAs (lncRNAs) drive HCC initiation progression have attracted increasing attention. However, research on ferroptosis-related lncRNA prognostic signature patients with still lacking. In this study, association between differentially lncRNAs...

10.3389/fimmu.2021.719175 article EN cc-by Frontiers in Immunology 2021-09-17

Abstract The cGAS-STING signaling pathway has emerged as a critical mediator of innate immune responses, playing crucial role in improving antitumor immunity through effector responses. Targeting the holds promise for overcoming immunosuppressive tumor microenvironments (TME) and promoting effective elimination. However, systemic administration current STING agonists faces challenges related to low bioavailability potential adverse effects, thus limiting their clinical applicability....

10.1186/s40364-023-00551-z article EN cc-by Biomarker Research 2024-01-07

The gasdermin (GSDM) superfamily has been demonstrated to consist of several important molecules that modulate multifunctional signal processes, such as cell pyroptosis. In this research, the roles GSDM on occurrence and prognosis lung adenocarcinoma (LUAD) were evaluated using integrative bioinformatic analyses in vitro methods. Here, data from platforms revealed GSDMC is significantly upregulated LUAD tissues lines. Real‑time fluorescence quantitative PCR (qPCR) was obviously...

10.3892/mmr.2019.10837 article EN cc-by-nc-nd Molecular Medicine Reports 2019-11-20

Background: LncRNAs have been shown to play essential roles in cancer therapeutic response. However, the detailed mechanism of lncRNAs temozolomide (TMZ) resistance glioblastoma (GBM) remain be elucidated. Methods: To elucidate maintaining TMZ resistance, we constructed two TMZ-resistant GBM cell lines (T98G-R/U118-R). from four public datasets were reanalyzed, and candidate lncRNA ADAMTS9-AS2 was evaluated TMZ-treated patients vitro lines. Results: Reanalysis expression profiles identified...

10.3389/fcell.2019.00217 article EN cc-by Frontiers in Cell and Developmental Biology 2019-10-02

Lipoic acid synthetase (LIAS) has been demonstrated to play a crucial role in the progression of cancer. Exploring underlying mechanisms and biological functions LIAS could have potential therapeutic guidance for cancer treatment. Our study explored expression levels prognostic values pan-cancer through several bioinformatics platforms, including TIMER2.0, Gene Expression Profiling Interactive Analysis, version 2 (GEPIA2.0), Human Protein Atlas (HPA). We found that high was related good...

10.3389/fonc.2022.952129 article EN cc-by Frontiers in Oncology 2022-08-02

Recent studies have discovered that tiny particles of microplastics (MPs) at the nano-scale level can enter body organisms from environment, potentially causing metabolic ailments. However, further investigation is required to understand alterations in immune microenvironment associated with non-alcoholic fatty liver disease (NAFLD) occurrence following exposure MPs. Experiments were performed using mice, which given a normal chow or high-fat diet (NCD HFD, respectively) plus free drinking...

10.1016/j.scitotenv.2023.168308 article EN cc-by The Science of The Total Environment 2023-11-15

Abstract Temozolomide (TMZ) represents a standard-of-care chemotherapeutic agent in glioblastoma (GBM). However, the development of drug resistance constitutes significant hurdle treatment malignant glioma. Although specific innovative approaches, such as immunotherapy, have shown favorable clinical outcomes, inherent invasiveness most gliomas continues to make them challenging treat. Consequently, there is an urgent need identify effective therapeutic targets for overcome chemoresistance...

10.1038/s41392-024-01763-x article EN cc-by Signal Transduction and Targeted Therapy 2024-03-04

10.1016/j.jtbi.2004.07.023 article EN Journal of Theoretical Biology 2004-09-24

Resistance to temozolomide (TMZ), the standard chemotherapy agent for glioblastoma (GBM), poses a major clinical challenge GBM prognosis. Understanding mechanisms of TMZ resistance can help identify novel drug targets and more effective therapies. Recent studies suggest that bioenergetic alterations cancer cells play important roles in resistance. In our study, altered metabolism was observed using metabolic PCR array. We found stearoyl-coenzyme A desaturase 1 (SCD1), key rate-limiting...

10.3389/fphar.2017.00960 article EN cc-by Frontiers in Pharmacology 2018-01-03

Glucose-6-phosphate dehydrogenase (G6PD) is a rate-limiting enzyme of the pentose phosphate pathway. Multiple studies have previously revealed that elevated G6PD levels promote cancer progression in numerous tumor types; however, underlying mechanism remains unclear. In present study, it was demonstrated high expression poor prognostic factor bladder cancer, and increase with increasing stage. Patients had worse survival rates compared those lower resected tumors. vitro experiments knockdown...

10.3892/ijo.2018.4501 article EN International Journal of Oncology 2018-07-25
Coming Soon ...